Daniel Kracov is a partner and co-head of the firm's Life Sciences and Healthcare Regulatory practice. He assists companies, trade associations and individuals in negotiating the broad range of regulatory and compliance challenges relating to the development, approval, manufacture, and marketing of drugs, biologics, medical devices and diagnostics. He handles complex investigations and enforcement matters, the development of corporate compliance programs, and due diligence in financings, mergers and acquisitions. He has a widely-recognized expertise in biomedical product-related public policy matters, including Congressional investigations.
JD, University of Virginia, 1988; BA, University of Maryland, 1985.